Position
President
Company
XenoSTART
San AntonioBiotechnologyHealth CareTherapeuticsDescription
The START Center for Cancer Research announced the appointment of Frank Smith, PhD, MBA, as President of XenoSTART, overseeing its operations and strategic vision. Dr. Smith is expected to enhance project delivery and quality systems while leading R&D efforts in oncology.
Quick answer
XenoSTART Appoints Frank Smith as President (February 24, 2026). XenoSTART is based in San Antonio, Texas, United States.
- Who is the new President at XenoSTART?
- XenoSTART named Frank Smith President, announced February 24, 2026.
- What did XenoSTART announce on February 24, 2026?
- The START Center for Cancer Research announced the appointment of Frank Smith, PhD, MBA, as President of XenoSTART, overseeing its operations and strategic vision. Dr. Smith is expected to enhance project delivery and quality systems while leading R&D efforts in oncology.
- What does XenoSTART do?
- XenoSTART is an industry-leading oncology translational research organization dedicated to advancing drug development through clinically relevant preclinical cancer models.
- Where is XenoSTART based?
- XenoSTART is based in San Antonio, Texas, United States.
- Which similar companies made leadership changes around the same time?
- Kenai Therapeutics (February 24, 2026), Foghorn Therapeutics (February 23, 2026), Insitro (February 26, 2026) and Pulse Biosciences, Inc. (February 27, 2026) also announced leadership changes within 45 days of XenoSTART.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Kenai Therapeutics Appoints Blake Arnold as Chief Business Officer (February 24, 2026)
- Foghorn Therapeutics Appoints Ryan Maynard as Chief Financial Officer (February 23, 2026)
- insitro Appoints Joe Hand as Chief People Officer (February 26, 2026)
- Pulse Biosciences Announces Resignation of Chief Commercial Officer (February 27, 2026)
- Argo Biopharma Appoints Gena Wang as Chief Financial Officer and Chief Strategy Officer (March 2, 2026)
- EyePoint Appoints Michael Campbell as Chief Commercial Officer (February 18, 2026)
Who to call at XenoSTART, and when
A new leader at XenoSTART brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day XenoSTART raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at XenoSTART, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at XenoSTART. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment XenoSTART changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
XenoSTART changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.